KEY PUBLICATIONS
Neuropeptide S Receptor 1 is a Novel Non-Hormonal Treatment Target in Endometriosis - Tapmeier T. et al, (2021), Science Translational Medicine (click for full text, click for reprint)
Endometriosis - Zondervan KT. et al, (2020), New England Journal of Medicine, 382, 1244 - 1256
The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis - Shigesi N. et al, (2019), Human Reproduction Update
Endometriosis - Zondervan KT. et al, (2018), Nature Reviews Disease Primers, 4
Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism - Sapkota Y. et al, (2017), Nature Communications, 8
Latest group publications
-
Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis.
Journal article
Tapmeier TT. et al, (2021), Sci Transl Med, 13
-
The global impact of COVID-19 on the care of people with endometriosis
Journal article
Demetriou L. et al, (2021), Frontiers in Global Women's Health
-
Genomic analysis identifies variants that can predict the timing of menopause.
Journal article
Zondervan KT., (2021), Nature, 596, 345 - 346
-
Neuropeptide S Receptor 1 is a Novel Non-Hormonal Treatment Target in Endometriosis
Journal article
Tapmeier T. et al, (2021), Science Translational Medicine
-
Discovery of Novel Molecular Mechanisms Underlying the Pathophysiology of Uterine Fibroids and Associated Heavy Menstrual Bleeding
Conference paper
Wang C-Y. et al, (2021), REPRODUCTIVE SCIENCES, 28, 133A - 133A
-
The Effect of Peritoneal Fluid-Derived Exosomes from Endometriosis Patients on Mesothelial Cells.
Conference paper
Li KY. et al, (2021), REPRODUCTIVE SCIENCES, 28, 225A - 225A
-
Hand Osteoarthritis: investigating Pain
Effects of estrogen-containing therapy
(HOPE-e): a protocol for a feasibility
randomised placebo-controlled trial
Journal article
MARIAN I. et al, (2021), Pilot and Feasibility Studies
-
IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG).
Journal article
Mouraux A. et al, (2021), Trials, 22
-
Development of a visual, patient-reported tool for assessing the multi-dimensional burden of endometriosis.
Journal article
As-Sanie S. et al, (2021), Curr Med Res Opin
-
An update on the management of chronic pelvic pain in women.
Journal article
Vincent K. and Evans E., (2021), Anaesthesia, 76 Suppl 4, 96 - 107